180 related articles for article (PubMed ID: 7368160)
1. Relative activities of heparin fractions obtained by gel chromatography.
Graham DT; Pomeroy AR
Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
[TBL] [Abstract][Full Text] [Related]
2. Relative Activities of Heparin Fractions Obtained by Gel Chromatography.
Graham DT; Pomeroy AR
Thromb Haemost; 1979 Jul; 42(1):1598-1603. PubMed ID: 30781914
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
[TBL] [Abstract][Full Text] [Related]
4. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
[TBL] [Abstract][Full Text] [Related]
5. Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.
Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP; Casu B; Torri G
Arzneimittelforschung; 1985; 35(8):1215-9. PubMed ID: 4074437
[TBL] [Abstract][Full Text] [Related]
6. Electrofocusing of heparin: Presence of 21 monomeric and dimeric molecular species in heparin preparations.
Dietrich CP; Nader HB; Mcduffie NN
An Acad Bras Cienc; 1975; 47(2):301-9. PubMed ID: 1233886
[TBL] [Abstract][Full Text] [Related]
7. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins.
Harenberg J; Siegele M; Dempfle CE; Stehle G; Heene DL
Thromb Haemost; 1993 Dec; 70(6):942-5. PubMed ID: 8165616
[TBL] [Abstract][Full Text] [Related]
8. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
Takahashi HK; Nader HB; Dietrich CP
Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
[TBL] [Abstract][Full Text] [Related]
9. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombin.
Bhargava AS; Heinick J; Günzel P
Arzneimittelforschung; 1980; 30(7):1071-4. PubMed ID: 7191289
[TBL] [Abstract][Full Text] [Related]
11. Production method affects the pharmacokinetic and ex vivo biological properties of low molecular weight heparins.
Brieger D; Dawes J
Thromb Haemost; 1997 Feb; 77(2):317-22. PubMed ID: 9157589
[TBL] [Abstract][Full Text] [Related]
12. In vitro protamine neutralization profiles of heparins differing in source and molecular weight.
Racanelli A; Hoppensteadt DA; Fareed J
Semin Thromb Hemost; 1989 Oct; 15(4):386-9. PubMed ID: 2554498
[No Abstract] [Full Text] [Related]
13. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
Chang LC; Lee HF; Chung MJ; Yang VC
Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of crude heparin and commercial preparation of Polish production].
Jarzebiński J; Tońska S; Remiszewska H
Acta Pol Pharm; 1989; 46(2):179-82. PubMed ID: 2561044
[TBL] [Abstract][Full Text] [Related]
15. Gel permeation chromatography of heparins.
Mulloy B; Johnson EA
Thromb Haemost; 1980 Jul; 43(3):192-3. PubMed ID: 7455984
[TBL] [Abstract][Full Text] [Related]
16. Enzymic depolymerization of macromolecular heparin as a factor in control of lipoprotein lipase activity.
Horner AA
Proc Natl Acad Sci U S A; 1972 Nov; 69(11):3469-73. PubMed ID: 4508335
[TBL] [Abstract][Full Text] [Related]
17. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
Poon MC; Hurst RE; Rives MS
Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
[TBL] [Abstract][Full Text] [Related]
18. Rapid molecular size characterization of heparins by high pressure liquid chromatography.
Sugisaka N; Petracek FJ
Fed Proc; 1977 Jan; 36(1):89-92. PubMed ID: 556606
[TBL] [Abstract][Full Text] [Related]
19. Complement inhibitory and anticoagulant activities of fractionated heparins.
Hennink WE; Klerx JP; van Dijk H; Feijen J
Thromb Res; 1984 Nov; 36(4):281-92. PubMed ID: 6523441
[TBL] [Abstract][Full Text] [Related]
20. Variability of heparin preparations in clinical use.
Jaques LB; Kavanagh LW
Thromb Diath Haemorrh Suppl; 1973; 56():171-80. PubMed ID: 4142115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
